With just a few months to go before Eli Lilly expects to launch its own oral GLP-1 obesity drug, Novo Nordisk is making the ...

The GLP-1 medication is now available via injection and pill.

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

While injectable medications have dominated the weight loss space for years, most people aren’t exactly pumped to stick a needle in their stomach on a weekly basis. Now, a potential game-changing ...

By Sriparna Roy Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U.S. in the first ...

Jan 23 (Reuters) - Novo Nordisk's Wegovy pill tracked 18,410 U.S. prescriptions in the first full week after its launch, ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

Novo Nordisk entered 2026 with fresh momentum after the U.S. launch of its oral Wegovy pill. Is the stock a buy now?

Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss medication on FOX Business, saying there's "a lot of excitement." ...

Novo Nordisk oral Wegovy records 3,071 prescriptions in four days. Shares jump 6.5% as Eli Lilly oral weight loss drug awaits ...

By Sriparna Roy Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed 18,410 times in the U.S. in the first full week ...